Literature DB >> 12061395

Coronary blood flow control is impaired at rest and during exercise in conscious diabetic dogs.

Johnathan D Tune1, Clement Yeh, Srinath Setty, Pu Zong, H Fred Downey.   

Abstract

This study tested whether diabetes mellitus impairs coronary blood flow control sufficiently to alter the balance between myocardial oxygen delivery and metabolism. Dogs (n = 7) were instrumented with catheters in the aorta and coronary sinus, and with a flow transducer on the circumflex coronary artery. Coronary blood flow, myocardial oxygen consumption (MVO2), heart rate and aortic pressure were measured at rest and during treadmill exercise before and after induction of diabetes with alloxan monohydrate (40 - 60 mg/kg). Arterial plasma glucose concentration increased from 4.6+/-0.2 mM in non-diabetic, control dogs to 20.2+/-2.3 mM one week after alloxan injection. In non-diabetic control dogs, exercise increased MVO2 3.1-fold, coronary blood flow 2.7-fold, and heart rate 2.4-fold. Coronary venous PO2 decreased from 19.4+/-0.6 mmHg at rest to 14.7+/-0.7 mmHg during exercise. Diabetes significantly attenuated exercise coronary hyperemia and reduced coronary venous PO2 at rest (15.6+/-0.5 mmHg) and during exercise (12.6+/-0.8 mmHg). Diabetes also significantly reduced myocardial oxygen delivery at each level of exercise. Acute hyperglycemia alone did not alter exercise-induced coronary vasodilation or reduce coronary venous PO2. These findings demonstrate that experimental diabetes attenuates functional coronary hyperemia and impairs the balance between coronary blood flow and myocardial metabolism. However, this deleterious effect is not related to acute hyperglycemia but to the chronic disease process of diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12061395     DOI: 10.1007/s003950200018

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  8 in total

Review 1.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

Review 2.  Guidelines for animal exercise and training protocols for cardiovascular studies.

Authors:  David C Poole; Steven W Copp; Trenton D Colburn; Jesse C Craig; David L Allen; Michael Sturek; Donal S O'Leary; Irving H Zucker; Timothy I Musch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-20       Impact factor: 4.733

Review 3.  Disentangling the Gordian knot of local metabolic control of coronary blood flow.

Authors:  Johnathan D Tune; Adam G Goodwill; Alexander M Kiel; Hana E Baker; Shawn B Bender; Daphne Merkus; Dirk J Duncker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-11-08       Impact factor: 4.733

4.  Requisite roles of LOX-1, JNK, and arginase in diabetes-induced endothelial vasodilator dysfunction of porcine coronary arterioles.

Authors:  Travis W Hein; Xin Xu; Yi Ren; Wenjuan Xu; Shu-Huai Tsai; Naris Thengchaisri; Lih Kuo
Journal:  J Mol Cell Cardiol       Date:  2019-04-20       Impact factor: 5.000

5.  Echocardiographic assessment of coronary artery flow in normal canines and model dogs with myocardial infarction.

Authors:  Nohwon Park; Jaehwan Kim; Miyoung Lee; Soyun Lee; Sunhye Song; Seungjun Lee; Soyoung Kim; Yangwoo Park; Kidong Eom
Journal:  J Vet Sci       Date:  2013-06-30       Impact factor: 1.672

6.  Bimodal Pattern of Coronary Microvascular Involvement in Diabetes Mellitus.

Authors:  Murat Sezer; Mehmet Kocaaga; Emre Aslanger; Adem Atici; Ahmet Demirkiran; Zehra Bugra; Sabahattin Umman; Berrin Umman
Journal:  J Am Heart Assoc       Date:  2016-11-14       Impact factor: 5.501

7.  Experimental animal models of coronary microvascular dysfunction.

Authors:  Oana Sorop; Jens van de Wouw; Selena Chandler; Vahagn Ohanyan; Johnathan D Tune; William M Chilian; Daphne Merkus; Shawn B Bender; Dirk J Duncker
Journal:  Cardiovasc Res       Date:  2020-03-01       Impact factor: 10.787

8.  A patient-specific approach to assessing blood pressure management in patients with hypertension and coronary artery disease.

Authors:  Jeffrey Yim; Simon W Rabkin
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-25       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.